Both in Pharmaceuticals
Monopar Therapeutics vs CytomX Therapeutics
Over the past year MNPR returned −14.6% and CTMX returned −29.8%; their daily moves had a correlation of 0.31.
MNPR −14.6% CTMX −29.8%Growth of $1, one year, split-adjusted
| Metric | MNPR | CTMX |
|---|---|---|
| Price | $71.91 | $2.29 |
| Market cap | $482.7M | $499.0M |
| Today | −2.02% | −2.97% |
| 1 month | −9.7% | −15.8% |
| 6 months | +37.9% | −45.7% |
| Year to date | +10.1% | −46.2% |
| 1 year | −10.0% | −31.0% |
| Revenue growth (YoY) | — | −92.4% |
| Gross margin | — | 100.0% |
| Net margin | — | −1457.4% |
| P/E (TTM) | — | — |
| Price / sales | — | 27.3× |
| Net cash | $134.3M | $330.3M |
| Dividend yield | — | — |
| Volatility (60d) | 49.2% | 67.2% |
| Short % of float | 23.3% | 21.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).